Glyceryl Trinitrate Accord- Uk

Glyceryl Trinitrate Accord‑Uk is a prescription oral medication whose active ingredient is glyceryl trinitrate. It belongs to the organic nitrate class and is marketed in the European Union. The product is formulated to deliver nitric‑oxide donors for vasodilation, helping to manage conditions such as angina pectoris. While the exact strength and dosage form are not specified, it is supplied in the brand name Accord‑Uk.

Glyceryl Trinitrate Accord‑Uk is primarily indicated for the relief and prevention of chest pain associated with reduced coronary blood flow.

- Acute angina pectoris episodes, providing rapid symptom relief. - Chronic stable angina as part of a long‑term management plan. - Prophylaxis of angina attacks before physical exertion or emotional stress. - Adjunct therapy in acute coronary syndrome to reduce myocardial oxygen demand. - Use in diagnostic testing for coronary artery disease when vasodilator response is required. - Management of variant (Prinzmetal) angina where coronary spasm is a factor.

Side effects of Glyceryl Trinitrate Accord‑Uk reflect its vasodilatory action and may vary in frequency.

Common: - Headache, often described as throbbing or pressure‑type. - Flushing or warmth in the face and neck. - Dizziness or light‑headedness, especially when standing quickly. - Low blood pressure (hypotension) with a sensation of faintness.

Serious: - Severe hypotension leading to syncope. - Rapid heart rate (tachycardia) or irregular rhythm. - Allergic reactions such as rash, itching, swelling, or difficulty breathing.

Before prescribing Glyceryl Trinitrate Accord‑Uk, clinicians should evaluate several safety considerations to minimise risk.

- Known hypersensitivity to glyceryl trinitrate or other organic nitrates. - Recent use of phosphodiesterase‑5 inhibitors (e.g., sildenafil) due to risk of profound hypotension. - Severe anemia, increased intracranial pressure, or closed‑angle glaucoma. - Unstable hemodynamic status, such as shock or severe heart failure. - Pregnancy and lactation status, as safety data are limited. - Concomitant use of other vasodilators or antihypertensive agents. - Elderly patients may be more susceptible to blood‑pressure drops.

Glyceryl Trinitrate Accord‑Uk can interact with several medicines; understanding these interactions helps avoid adverse events.

Avoid: - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil) – may cause dangerous hypotension. - Other nitrate preparations – risk of additive vasodilation and severe blood‑pressure fall. - Guanylate cyclase stimulators – enhanced nitric‑oxide effects.

Use with caution: - Antihypertensive drugs (beta‑blockers, ACE inhibitors, calcium‑channel blockers) – monitor blood pressure. - Alcohol – may increase vasodilatory response and dizziness. - Diuretics – potential for amplified hypotensive effect.